United States Ocyodinic Market Report 2017

January 2017 | 115 pages | ID: U1D251922EAEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Ocyodinic

Revenue, means the sales value of Ocyodinic

This report studies sales (consumption) of Ocyodinic in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Fresenius Kaci
• Biofutura
• Baxter Healthcare
• Pfizer
• Ferring
• Novartis
• Teva Pharmaceutical Industries

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Natural Oxytocin
• Synthetic Oxytocin Derivative

Split by applications, this report focuses on sales, market share and growth rate of Ocyodinic in each application, can be divided into

• Hospitals
• Maternity Clinics

Contents

United States Ocyodinic Market Report 2017

1 OCYODINIC OVERVIEW

1.1 Product Overview and Scope of Ocyodinic
1.2 Classification of Ocyodinic
  1.2.1 Natural Oxytocin
  1.2.2 Synthetic Oxytocin Derivative
1.3 Application of Ocyodinic
  1.3.1 Hospitals
  1.3.2 Maternity Clinics
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Ocyodinic (2012-2022)
  1.4.1 United States Ocyodinic Sales and Growth Rate (2012-2022)
  1.4.2 United States Ocyodinic Revenue and Growth Rate (2012-2022)

2 UNITED STATES OCYODINIC COMPETITION BY MANUFACTURERS

2.1 United States Ocyodinic Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Ocyodinic Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Ocyodinic Average Price by Manufactures (2015 and 2016)
2.4 Ocyodinic Market Competitive Situation and Trends
  2.4.1 Ocyodinic Market Concentration Rate
  2.4.2 Ocyodinic Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES OCYODINIC SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2012-2017)

3.1 United States Ocyodinic Sales and Market Share by States (2012-2017)
3.2 United States Ocyodinic Revenue and Market Share by States (2012-2017)
3.3 United States Ocyodinic Price by States (2012-2017)

4 UNITED STATES OCYODINIC SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2012-2017)

4.1 United States Ocyodinic Sales and Market Share by Type (2012-2017)
4.2 United States Ocyodinic Revenue and Market Share by Type (2012-2017)
4.3 United States Ocyodinic Price by Type (2012-2017)
4.4 United States Ocyodinic Sales Growth Rate by Type (2012-2017)

5 UNITED STATES OCYODINIC SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Ocyodinic Sales and Market Share by Application (2012-2017)
5.2 United States Ocyodinic Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES OCYODINIC MANUFACTURERS PROFILES/ANALYSIS

6.1 Fresenius Kaci
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Ocyodinic Product Type, Application and Specification
    6.1.2.1 Natural Oxytocin
    6.1.2.2 Synthetic Oxytocin Derivative
  6.1.3 Fresenius Kaci Ocyodinic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Biofutura
  6.2.2 Ocyodinic Product Type, Application and Specification
    6.2.2.1 Natural Oxytocin
    6.2.2.2 Synthetic Oxytocin Derivative
  6.2.3 Biofutura Ocyodinic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Baxter Healthcare
  6.3.2 Ocyodinic Product Type, Application and Specification
    6.3.2.1 Natural Oxytocin
    6.3.2.2 Synthetic Oxytocin Derivative
  6.3.3 Baxter Healthcare Ocyodinic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Pfizer
  6.4.2 Ocyodinic Product Type, Application and Specification
    6.4.2.1 Natural Oxytocin
    6.4.2.2 Synthetic Oxytocin Derivative
  6.4.3 Pfizer Ocyodinic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Ferring
  6.5.2 Ocyodinic Product Type, Application and Specification
    6.5.2.1 Natural Oxytocin
    6.5.2.2 Synthetic Oxytocin Derivative
  6.5.3 Ferring Ocyodinic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Novartis
  6.6.2 Ocyodinic Product Type, Application and Specification
    6.6.2.1 Natural Oxytocin
    6.6.2.2 Synthetic Oxytocin Derivative
  6.6.3 Novartis Ocyodinic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Teva Pharmaceutical Industries
  6.7.2 Ocyodinic Product Type, Application and Specification
    6.7.2.1 Natural Oxytocin
    6.7.2.2 Synthetic Oxytocin Derivative
  6.7.3 Teva Pharmaceutical Industries Ocyodinic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 OCYODINIC MANUFACTURING COST ANALYSIS

7.1 Ocyodinic Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Ocyodinic

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Ocyodinic Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Ocyodinic Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES OCYODINIC MARKET FORECAST (2017-2022)

11.1 United States Ocyodinic Sales, Revenue Forecast (2017-2022)
11.2 United States Ocyodinic Sales Forecast by Type (2017-2022)
11.3 United States Ocyodinic Sales Forecast by Application (2017-2022)
11.4 Ocyodinic Price Forecast (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Ocyodinic
Table Classification of Ocyodinic
Figure United States Sales Market Share of Ocyodinic by Type in 2015
Figure Natural Oxytocin Picture
Figure Synthetic Oxytocin Derivative Picture
Table Application of Ocyodinic
Figure United States Sales Market Share of Ocyodinic by Application in 2015
Figure Hospitals Examples
Figure Maternity Clinics Examples
Figure United States Ocyodinic Sales and Growth Rate (2012-2022)
Figure United States Ocyodinic Revenue and Growth Rate (2012-2022)
Table United States Ocyodinic Sales of Key Manufacturers (2015 and 2016)
Table United States Ocyodinic Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Ocyodinic Sales Share by Manufacturers
Figure 2016 Ocyodinic Sales Share by Manufacturers
Table United States Ocyodinic Revenue by Manufacturers (2015 and 2016)
Table United States Ocyodinic Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Ocyodinic Revenue Share by Manufacturers
Table 2016 United States Ocyodinic Revenue Share by Manufacturers
Table United States Market Ocyodinic Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Ocyodinic Average Price of Key Manufacturers in 2015
Figure Ocyodinic Market Share of Top 3 Manufacturers
Figure Ocyodinic Market Share of Top 5 Manufacturers
Table United States Ocyodinic Sales by States (2012-2017)
Table United States Ocyodinic Sales Share by States (2012-2017)
Figure United States Ocyodinic Sales Market Share by States in 2015
Table United States Ocyodinic Revenue and Market Share by States (2012-2017)
Table United States Ocyodinic Revenue Share by States (2012-2017)
Figure Revenue Market Share of Ocyodinic by States (2012-2017)
Table United States Ocyodinic Price by States (2012-2017)
Table United States Ocyodinic Sales by Type (2012-2017)
Table United States Ocyodinic Sales Share by Type (2012-2017)
Figure United States Ocyodinic Sales Market Share by Type in 2015
Table United States Ocyodinic Revenue and Market Share by Type (2012-2017)
Table United States Ocyodinic Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Ocyodinic by Type (2012-2017)
Table United States Ocyodinic Price by Type (2012-2017)
Figure United States Ocyodinic Sales Growth Rate by Type (2012-2017)
Table United States Ocyodinic Sales by Application (2012-2017)
Table United States Ocyodinic Sales Market Share by Application (2012-2017)
Figure United States Ocyodinic Sales Market Share by Application in 2015
Table United States Ocyodinic Sales Growth Rate by Application (2012-2017)
Figure United States Ocyodinic Sales Growth Rate by Application (2012-2017)
Table Fresenius Kaci Basic Information List
Table Fresenius Kaci Ocyodinic Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Fresenius Kaci Ocyodinic Sales Market Share (2012-2017)
Table Biofutura Basic Information List
Table Biofutura Ocyodinic Sales, Revenue, Price and Gross Margin (2012-2017)
Table Biofutura Ocyodinic Sales Market Share (2012-2017)
Table Baxter Healthcare Basic Information List
Table Baxter Healthcare Ocyodinic Sales, Revenue, Price and Gross Margin (2012-2017)
Table Baxter Healthcare Ocyodinic Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Ocyodinic Sales, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Ocyodinic Sales Market Share (2012-2017)
Table Ferring Basic Information List
Table Ferring Ocyodinic Sales, Revenue, Price and Gross Margin (2012-2017)
Table Ferring Ocyodinic Sales Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Ocyodinic Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Ocyodinic Sales Market Share (2012-2017)
Table Teva Pharmaceutical Industries Basic Information List
Table Teva Pharmaceutical Industries Ocyodinic Sales, Revenue, Price and Gross Margin (2012-2017)
Table Teva Pharmaceutical Industries Ocyodinic Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ocyodinic
Figure Manufacturing Process Analysis of Ocyodinic
Figure Ocyodinic Industrial Chain Analysis
Table Raw Materials Sources of Ocyodinic Major Manufacturers in 2015
Table Major Buyers of Ocyodinic
Table Distributors/Traders List
Figure United States Ocyodinic Production and Growth Rate Forecast (2017-2022)
Figure United States Ocyodinic Revenue and Growth Rate Forecast (2017-2022)
Table United States Ocyodinic Production Forecast by Type (2017-2022)
Table United States Ocyodinic Consumption Forecast by Application (2017-2022)
Table United States Ocyodinic Sales Forecast by States (2017-2022)
Table United States Ocyodinic Sales Share Forecast by States (2017-2022)